Kiromic BioPharma, Inc.
KRBPQ
$0.0615
-$0.083-57.44%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 12.68% | -8.92% | -11.01% | -31.06% | -11.85% |
| Total Depreciation and Amortization | 2.90% | -0.90% | 0.00% | 0.36% | -1.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 764.85% | 158.38% | -12.32% | -89.47% | 1,045.14% |
| Change in Net Operating Assets | -141.56% | 313.30% | -557.37% | 90.27% | -147.51% |
| Cash from Operations | -88.92% | 76.39% | -43.53% | -5.36% | -3.48% |
| Capital Expenditure | 87.21% | -123.47% | -366.67% | 80.73% | -11.22% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 87.21% | -123.47% | -366.67% | 80.73% | -11.22% |
| Total Debt Issued | 122.62% | -87.35% | 38.70% | 45.45% | -38.89% |
| Total Debt Repaid | 11.46% | 0.00% | 53.85% | -264.91% | 66.67% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 96.43% |
| Cash from Financing | 135.15% | -88.30% | 41.81% | 42.61% | -37.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.29% | -323.26% | 6.57% | 140.14% | -170.17% |